Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
BBP
70
HOLDINGS
16%
ALSO IN XPH
XPH
60
HOLDINGS
17%
ALSO IN BBP
SECTOR DRIFT (BBP minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
NUVATION BIO INC CLASS A | 1.6% | 1.9% | 1.6% |
|
LIGAND PHARMACEUTICALS-CL B | 1.5% | 1.8% | 1.5% |
|
CRINETICS PHARMACEUTICALS INC | 1.5% | 3.7% | 1.5% |
|
TARSUS PHARMACEUTICALS, INC. | 1.5% | 1.5% | 1.5% |
|
LIQUIDIA TECHNOLOGIES, INC. | 1.4% | 1.8% | 1.4% |
BBP Overweight Relative to XPH
|
MODERNA, INC. | 1.9% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
|
SAREPTA THERAPEUTICS INC | 1.6% |
|
ULTRAGENYX PHARMACEUTICAL IN | 1.6% |
|
CYTOKINETICS INC | 1.6% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.6% |
|
KRYSTAL BIOTECH, INC. | 1.6% |
|
KURA ONCOLOGY, INC. | 1.6% |
|
GERON CORP | 1.6% |
|
RHYTHM PHARMACEUTICALS, INC. | 1.6% |
BBP Underweight Relative to XPH
|
MBX BIOSCIENCES INC | -3.1% |
|
DEFINIUM THERAPEUTICS INC | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.2% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
ALUMIS INC | -2.1% |
|
TREVI THERAPEUTICS, INC. | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.0% |
|
HARROW INC | -2.0% |
|
EDGEWISE THERAPEUTICS, INC. | -1.8% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -1.8% |